Table 2 Demographic and clinical variables of patient sub-groups
From: Cytokine levels reflect tic symptoms more prominently during mild phases
Mild (n = 13) | Above moderate (n = 22) | p value | |
|---|---|---|---|
Sex (male/female) | 10/3 | 18/4 | |
Age (years) | 7.46 ± 1.61 | 10.55 ± 2.82 | 0.001* |
IQ | 90.77 ± 10.787 | 97.18 ± 9.19 | 0.070 |
Duration until visit (months) | 22.50 ± 16.90 | 56.86 ± 40.44 | 0.002* |
YGTSS score | 14.46 ± 6.62 | 30.55 ± 12.70 | > 0.001* |
Motor tic score | 4.85 ± 3.72 | 8.32 ± 3.46 | 0.009* |
Phonic tic score | 1.15 ± 2.82 | 6.77 ± 4.23 | > 0.001* |
Total tic score | 6.00 ± 3.11 | 15.09 ± 5.37 | > 0.001* |
Impairment score | 8.46 ± 3.76 | 15.45 ± 8.58 | 0.002* |
Comorbidities (male/female) | |||
ADHD | 5/1 | 4/1 | |
Generalized anxiety disorder | 1/0 | 0/0 | |
Enuresis | 0/0 | 1/0 |